Exploration of the medical periodic table: towards new targets.
about
An Organometallic Inhibitor for the Human Repair Enzyme 7,8-Dihydro-8-oxoguanosine TriphosphataseNon-ATP-Mimetic Organometallic Protein Kinase InhibitorCytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivativesUnusual Synergism of Transferrin and Citrate in the Regulation of Ti(IV) Speciation, Transport, and ToxicityPotentiating effect of UVA irradiation on anticancer activity of Carboplatin derivatives involving 7-azaindolesThe elements of life and medicinesDownregulation of oncogenic RAS and c-Myc expression in MOLT-4 leukaemia cells by a salicylaldehyde semicarbazone copper(II) complexChemical Swarming: Depending on Concentration, an Amphiphilic Ruthenium Polypyridyl Complex Induces Cell Death via Two Different MechanismsHydrogen bonding and anticancer properties of water-soluble chiral p-cymene Ru(II) compounds with amino-oxime ligandsIn-cell NMR: an emerging approach for monitoring metal-related events in living cells.Organometallic Half-Sandwich Dichloridoruthenium(II) Complexes with 7-Azaindoles: Synthesis, Characterization and Elucidation of Their Anticancer Inactivity against A2780 Cell Line.DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.New bimetallic palladium(ii) and platinum(ii) complexes: studies of the nucleophilic substitution reactions, interactions with CT-DNA, bovine serum albumin and cytotoxic activity.In Vitro Antitumor Active Gold(I) Triphenylphosphane Complexes Containing 7-Azaindoles.Carbon monoxide--physiology, detection and controlled release.Rhenium Complexes with Red-Light-Induced Anticancer Activity.Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C(∧)N-Chelated and Pyridine Ligands.The potent oxidant anticancer activity of organoiridium catalysts.Quantitative bioimaging by LA-ICP-MS: a methodological study on the distribution of Pt and Ru in viscera originating from cisplatin- and KP1339-treated mice.Systems approach to metal-based pharmacology.Oxidative metabolism of ferrocene analogues of tamoxifen: characterization and antiproliferative activities of the metabolites.Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.Ferrocenyl Quinone Methide-Thiol Adducts as New Antiproliferative Agents: Synthesis, Metabolic Formation from Ferrociphenols, and Oxidative Transformation.Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.Enhancement of the physicochemical properties of [Pt(dien)(nucleobase)]2+ for HIVNCp7 targeting.Automatic assignment of metal-containing peptides in proteomic LC-MS and MS/MS data sets.Inhibition of cancer cell growth by ruthenium complexesDicopper(II) and dizinc(II) complexes with nonsymmetric dinucleating ligands based on indolo[3,2-c]quinolines: synthesis, structure, cytotoxicity, and intracellular distribution.Dual mode of cell death upon the photo-irradiation of a RuII polypyridyl complex in interphase or mitosis.Chelation Motifs Affecting Metal-dependent Viral Enzymes: N'-acylhydrazone Ligands as Dual Target Inhibitors of HIV-1 Integrase and Reverse Transcriptase Ribonuclease H DomainMetallomics insights into the programmed cell death induced by metal-based anticancer compounds.Current and potential applications of bismuth-based drugs.DNA or protein? Capillary zone electrophoresis-mass spectrometry rapidly elucidates metallodrug binding selectivity.Kinetic and mechanistic study on the reactions of ruthenium(ii) chlorophenyl terpyridine complexes with nucleobases, oligonucleotides and DNA.Multi-platinum anti-cancer agents. Substitution-inert compounds for tumor selectivity and new targets.Ferrocifen type anti cancer drugs.Synthesis, Molecular Structure and Cytotoxicity of Molecular Materials Based on Water Soluble Half-Sandwich Rh(III) and Ir(III) Tetranuclear Metalla-Cycles.Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells.Structurally related hydrazone-based metal complexes with different antitumor activities variably induce apoptotic cell death.Reversible Covalent and Supramolecular Functionalization of Water-Soluble Gold(I) Complexes.
P2860
Q27680660-F7339251-C37B-44E8-822B-F8D56C65BC90Q27681838-A261F795-93B9-40F7-B241-3F585422570FQ27702884-E1FDC276-303C-4253-84DC-AF792A112E00Q28394138-4DCF494C-1CB3-43DC-B99D-43432E4F85E1Q28546440-D1BD3A71-4D16-4DD0-A3DC-DD2ABC5CBD5AQ28649323-736FCDAE-875A-4E61-A28B-239B7F3ABF8BQ28821489-CC05546D-19A6-445D-9262-9E1689C588D3Q28822145-C024D481-CB57-42EA-8ED0-F5573BCCC2AEQ28834484-240BC062-22B4-468E-B0C5-6DB9BF3F89B4Q30355333-6531E340-613E-4834-BF5A-CFD82D4890DBQ31028118-EDC9E737-112E-4F44-AEA7-1AFB625033ACQ31043552-7E3C9CF5-0461-4222-9451-9B5E81B9B563Q31115563-F20F17BC-DB19-4A1F-9D17-ABDE58391751Q31148784-A8D0AD17-CD6E-400B-A892-8254C37924C5Q33811171-473FD502-2F9F-47DE-A94B-EBC9B5B4553CQ33919088-6356D128-7DA6-4E30-B36A-EEB0911E7C30Q34331245-B7D04668-F010-449C-89B8-90591CDE0274Q34488624-AA9BFB48-968C-4AEA-9FB7-1D210E744E8FQ35167846-2498A312-C067-434E-9477-D0063C3D73A5Q35378343-732A9128-FE1A-4511-B12E-29F97554EE0AQ35604815-E84B9C9A-9A3C-451E-94E8-4DFD8A6C9565Q35895492-1A161F99-5618-4B1A-859C-85C1905CFABEQ36045117-CBE6BE2D-4DA5-42F4-B3BB-1E3E4C4B8018Q36146681-414F5C21-7317-4B74-AC73-9FE725ECDE8EQ36357319-8D48B626-6EB8-4375-A9BB-2F94F4CC78FEQ36373894-24ABCDEF-F206-41C9-ADF3-C63F85589E19Q36574799-487BBC2A-20AD-454F-A850-3AACA9A27498Q37148450-0C39CEA4-43F4-46B9-9716-4A35BE0D1B6AQ37274934-1792D8BC-2CE3-4A87-9E66-ECC66AD22861Q37710343-E6BCC5AF-C30B-4863-B0E1-3D8205EAF4BAQ38199383-7AF6D245-DA97-49FE-B935-6DF75D40A8E0Q38253836-16064FC7-D58E-4179-8584-3032AF58728EQ38287806-1C579F93-DF03-4697-809D-E9D71ED39C6DQ38289233-1973DD5C-ED5E-495C-9CCD-76F9687A209CQ38465028-84EE5F1A-5B66-43BB-8690-6664E6080659Q38612680-3B49C728-8784-4520-9261-CCE94571185AQ38634005-F181B4B3-9AF2-4972-A329-F95907FA5A2DQ38701263-64FF3131-33A8-4064-A0CB-39EDE634B950Q38710830-AFB3265A-C94C-4262-8626-D66955C7A5DDQ38717137-BE5F5639-C422-45F6-93B2-C25B2F5DCA80
P2860
Exploration of the medical periodic table: towards new targets.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Exploration of the medical periodic table: towards new targets.
@en
Exploration of the medical periodic table: towards new targets.
@nl
type
label
Exploration of the medical periodic table: towards new targets.
@en
Exploration of the medical periodic table: towards new targets.
@nl
prefLabel
Exploration of the medical periodic table: towards new targets.
@en
Exploration of the medical periodic table: towards new targets.
@nl
P356
P1476
Exploration of the medical periodic table: towards new targets.
@en
P2093
Nicolas P E Barry
Peter J Sadler
P304
P356
10.1039/C3CC41143E
P407
P577
2013-06-01T00:00:00Z